Globus Medical, Inc. (GMED)

Market Cap	8.48B
Revenue (ttm)	2.63B
Net Income (ttm)	356.65M
Shares Out	135.06M
EPS (ttm)	2.57
PE Ratio	24.40
Forward PE	18.46
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,563,986
Open	61.90
Previous Close	61.87
Day's Range	61.66 - 63.11
52-Week Range	51.79 - 94.93
Beta	1.20
Analysts	Buy
Price Target	87.30 (+39.04%)
Earnings Date	Aug 7, 2025

About GMED

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip a...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 3, 2012
• Employees: 5,300
• Stock Exchange: NYSE
• Ticker Symbol: GMED
• Website: https://www.globusmedical.com

Financial Performance

In 2024, Globus Medical's revenue was $2.52 billion, an increase of 60.62% compared to the previous year's $1.57 billion. Earnings were $102.98 million, a decrease of -16.19%.

Analyst Forecast

According to 13 analysts, the average rating for GMED stock is "Buy." The 12-month stock price target is $87.3, which is an increase of 39.04% from the latest price.

Price Target

$87.3

(39.04% upside)

Analyst Consensus: Buy